Translational Development Acquisition (TDAC) Total Liabilities (2023 - 2026)
Translational Development Acquisition's Total Liabilities history spans 4 years, with the latest figure at $6.9 million for Q1 2026.
- On a quarterly basis, Total Liabilities rose 8.46% to $6.9 million in Q1 2026 year-over-year; TTM through Mar 2026 was $6.9 million, a 8.46% increase, with the full-year FY2025 number at $6.6 million, up 5.34% from a year prior.
- Total Liabilities came in at $6.9 million for Q1 2026, up from $6.6 million in the prior quarter.
- The five-year high for Total Liabilities was $6.9 million in Q1 2026, with the low at $509343.0 in Q2 2024.
- Historically, Total Liabilities has averaged $4.5 million across 4 years, with a median of $6.3 million in 2025.
- Peak annual rise in Total Liabilities hit 1141.24% in 2025, while the deepest fall reached 5.34% in 2025.
- Year by year, Total Liabilities stood at $509679.0 in 2023, then surged by 1125.83% to $6.2 million in 2024, then grew by 5.34% to $6.6 million in 2025, then grew by 4.82% to $6.9 million in 2026.
- Business Quant data shows Total Liabilities for TDAC at $6.9 million in Q1 2026, $6.6 million in Q4 2025, and $6.5 million in Q3 2025.